Investors interested in Medical Info Systems stocks are likely familiar with Inspire Medical Systems (INSP) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks offers value investors a better bang for their buck right now?
Inspire Medical Systems, Inc. (INSP) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript
Bamco Inc. NY decreased its holdings in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by 61.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 190,023 shares of the company's stock after selling 301,729 shares during the quarter.
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
Inspire Medical continues to grow on strong Q4 results and continued R&D investments as the company advances its sleep apnea therapy.
Inspire Medical Systems faces intensifying competition, reimbursement headwinds, and decelerating growth in the obstructive sleep apnea device market. Despite Q4 revenue and EPS beats, FY26 guidance implies just 4–10% revenue growth, higher capex, and a projected net loss amid operational challenges. Valuation remains stretched even after a 66% stock decline; DCF analysis suggests current pricing bakes in optimistic growth and margin assumptions.
INSP beats Q4 estimates with EPS up 43% and wider margins, but shares tumble 8.7% after a lower 2026 revenue outlook.
Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript
Inspire Medical Systems (INSP) came out with quarterly earnings of $1.65 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $1.15 per share a year ago.
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
INSP navigates a product shift as Inspire V gains traction, reimbursement improves, and management balances growth with near-term pressures.
Inspire Medical Systems, Inc. (INSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript